{"url_path":"/sec/cdna/8-k/2026-07-07/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 Regulation FD Disclosure.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-07","source_url":"https://www.sec.gov/Archives/edgar/data/1217234/0001217234-26-000038-index.html","accession_number":"0001217234-26-000038","cik":"0001217234","ticker":"CDNA","issuer_name":"CareDx, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1217234/0001217234-26-000038-index.html","primary_entity_key":"0001217234","primary_entity_name":"CareDx, Inc."},"word_count":181,"has_tables":true,"body_markdown":"Item 7.01. Regulation FD Disclosure.\n\nOn June 30, 2026, the Company issued a press release (the “Eurobio Press Release”) announcing the closing of the Eurobio Transaction. A copy of the Eurobio Press Release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.\n\nOn July 1, 2026, the Company issued a press release (the “Naveris Press Release”) announcing the closing of the Naveris Transaction. A copy of the Naveris Press Release is furnished as Exhibit 99.2 to this Current Report on Form 8-K and is incorporated herein by reference.\n\nThe information set forth in this Item 7.01 and in the attached Exhibits 99.1 and 99.2 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing."}